Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.27
▾0.00 (0.00%)
Last trade: 09/09, 6:18AM
Market cap
$58.75m
Trading Suspended
Talk to TBG Diagnostics Limited directly.
Sign up to their Investor Hub for direct access to the TBG Diagnostics Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
TBG Diagnostics Limited (TDL, formerly Progen Pharmaceuticals Limited) is a biotechnology company focused on the global molecular diagnostic industry and is involved in the development, manufacture and marketing of molecular diagnostic kits, instruments and services. The company's operating Segment includes � In Vitro Diagnostics. Former Names Progen Industries Limited (PGL), 02/04/2007; Progen Pharmaceuticals Limited (PGL), 02/02/2016
Address
Level 18/101 Collins St, Melbourne VIC 3000, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.27
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.